Product Information
TELMISARTAN 20 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1070 per EA under NDC 67877048230. Its NADAC has been published 343 times since Dec 4, 2019.
Strength
20 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877048230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205150On Market Since
6/12/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 20 MG TABLET has been published 343 times since Dec 4, 2019, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1070 per EA |
|---|---|
| All-time high | $0.6122 (Mar 11, 2020) |
| All-time low | $0.1044 (Mar 18, 2026) |
| 52-week high | $0.1174 |
| 52-week low | $0.1044 |
| Median price | $0.1941 |
| Average price | $0.2556 |
| Largest weekly change | +34.5% (Aug 21, 2024) |
| Weeks tracked | 343 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 20 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1070 per EA (NDC 67877048230), effective Jun 24, 2026.
How has the price of TELMISARTAN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 20 MG TABLET has declined 75.2%. It has been tracked across 343 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 20 MG TABLET?
Since Dec 4, 2019, the NADAC for TELMISARTAN 20 MG TABLET has ranged from a low of $0.1044 (Mar 18, 2026) to a high of $0.6122 (Mar 11, 2020), with a median of $0.1941 per EA.
Are there cheaper alternatives to TELMISARTAN 20 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN 20 MG TABLET, but none are currently priced below it.
Who manufactures TELMISARTAN 20 MG TABLET?
TELMISARTAN 20 MG TABLET (NDC 67877048230) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification